Omeprazole First
For GERD, start with omeprazole (a proton pump inhibitor), not sucralfate (Carafate). PPIs are the first-line pharmacologic therapy for GERD based on strong evidence showing superior efficacy for both symptom relief and healing of esophagitis 1, 2.
Why Omeprazole Over Carafate
The American Gastroenterological Association gives Grade A recommendation (strongly recommended based on good evidence) for PPIs as antisecretory drugs for treating esophageal GERD syndromes, stating that "proton pump inhibitors (PPIs) are more effective than histamine 2 receptor antagonists (HRAs), which are more effective than placebo" 1. Notably, sucralfate is not even mentioned in current GERD treatment guidelines as a first-line or alternative therapy 1, 2.
The most recent 2022 AGA Clinical Practice Update explicitly recommends: "Clinicians should provide patients presenting with troublesome heartburn, regurgitation, and/or non-cardiac chest pain without alarm symptoms a 4- to 8-week trial of single-dose PPI therapy" 2. This represents the current standard of care.
Practical Implementation
Dosing specifics:
- Start omeprazole 20 mg once daily 3
- Take 30-60 minutes before a meal 2
- Continue for 4-8 weeks initially 2, 3
- If inadequate response, increase to twice daily before escalating to other options 2
Why This Matters for Outcomes
PPIs directly address the pathophysiology of GERD by providing sustained inhibition of gastric acid secretion, which is necessary to:
- Heal eroded esophageal mucosa 4
- Prevent complications like strictures, Barrett's esophagus, and esophageal adenocarcinoma 5
- Improve quality of life through symptom relief 6, 5
Sucralfate, a mucoprotective agent, has been studied in GERD but lacks the robust evidence base supporting PPIs and is not recommended in modern guidelines 1, 2, 6.
Common Pitfalls to Avoid
- Don't start with H2 blockers or antacids when PPIs are indicated—they are less effective 1
- Don't skip the pre-meal timing—taking omeprazole 30-60 minutes before eating optimizes acid suppression 2
- Don't continue empiric therapy indefinitely without reassessment—evaluate response at 4-8 weeks and consider objective testing if symptoms persist 2
- Don't avoid PPIs due to overblown safety concerns—while long-term PPI use requires monitoring, the benefits for proven GERD far outweigh theoretical risks 2, 5
When to Escalate
If symptoms don't respond adequately to twice-daily PPI therapy, this represents treatment failure requiring objective testing (endoscopy and pH monitoring) rather than switching to alternative agents like sucralfate 2.